CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
The Breast Cancer Self-Care Appdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05576545
NCT05576545N/ACompleted
CompareCT.gov

Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment

Kaohsiung Medical University Chung-Ho Memorial Hospital·interventional·Posted Oct 12, 2022·Updated Oct 12, 2022

In Brief

A clinical study evaluating The Breast Cancer Self-Care App for Breast Cancer and 4 related conditions. Completed, enrolled 73 participants across 1 site.

Detailed Summary

This study was to develop and evaluate the self-efficacy and resilience of the Breast Cancer Self-Care App in newly diagnosed breast cancer patients undergoing chemotherapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Breast Neoplasm, Breast Malignant Tumor, Resilience, Self-efficacy
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 12, 2022
Enrollment StartSep 18, 2020
Primary CompletionAug 15, 2022
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 3.7 years ago

Interventions

The Breast Cancer Self-Care Appdevice

The Breast Cancer Self-Care App includes several parts- introduction to breast cancer, types of treatment, side effects care, nutrition, relaxation videos, insurance, medical news and recording side effects, etc. The researcher assisted in installing the App on the patient's mobile phone, entered the personal account, and asked the patient to fill in questionnaires. Patients were given individual health education task in the Breast Cancer Self-Care App every week according to the type of chemotherapy drugs. After four weeks, they filled in questionnaires again.